Interestingly, TET1 was a highly significant predictor of improved survival in colorectal cancer and melanoma patients (Fig. 3D, E), though there was no relationship between TET1 mutation and survival in bladder cancer (P = 0.209). Here, TET1 is linked to colorectal cancer.